Literature DB >> 11447272

Multiple vesiculoviral matrix proteins inhibit both nuclear export and import.

J M Petersen1, L S Her, J E Dahlberg.   

Abstract

The matrix (M) protein of vesicular stomatitis virus inhibits both nuclear import and export. Here, we demonstrate that this inhibitory property is conserved between the M proteins from two other vesiculoviruses, chandipura virus and spring viremia carp virus. All three M proteins completely block nuclear transport of spliced mRNA, small nuclear RNAs, and small nuclear ribonucleoproteins and slow the nuclear transport of many other cargoes. In all cases where transport was merely slowed by the M proteins, the chandipura virus M protein had the strongest inhibitory activity. When expressed in transfected HeLa cells, active M proteins displayed prominent association with the nuclear rim. Moreover, mutation of a conserved methionine abolished both the inhibitory activity and efficient targeting of the M proteins to the nuclear rim. We propose that all of the vesiculoviral M proteins associate with the same nuclear target, which is likely to be a component of the nuclear pore complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447272      PMCID: PMC37480          DOI: 10.1073/pnas.151240998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Transport between the cell nucleus and the cytoplasm.

Authors:  D Görlich; U Kutay
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98.

Authors:  J P Rodrigues; D Sitterlin; A Bachi; X Wu; M Wilm; M Carmo-Fonseca; E Izaurralde
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

3.  Coupling of nuclear RNA export and protein import in vertebrate cells.

Authors:  J E Dahlberg; E Lund
Journal:  Semin Cell Dev Biol       Date:  1997-02       Impact factor: 7.727

Review 4.  Nucleocytoplasmic transport: the soluble phase.

Authors:  I W Mattaj; L Englmeier
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 5.  Importins and exportins: how to get in and out of the nucleus.

Authors:  K Weis
Journal:  Trends Biochem Sci       Date:  1998-05       Impact factor: 13.807

6.  Identification of a nuclear export receptor for tRNA.

Authors:  G J Arts; M Fornerod; I W Mattaj
Journal:  Curr Biol       Date:  1998-03-12       Impact factor: 10.834

7.  Selection and nuclear immobilization of exportable RNAs.

Authors:  C Grimm; E Lund; J E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

8.  The nucleoporin nup153 plays a critical role in multiple types of nuclear export.

Authors:  K S Ullman; S Shah; M A Powers; D J Forbes
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

9.  TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus.

Authors:  P Grüter; C Tabernero; C von Kobbe; C Schmitt; C Saavedra; A Bachi; M Wilm; B K Felber; E Izaurralde
Journal:  Mol Cell       Date:  1998-04       Impact factor: 17.970

10.  Sequence and characterization of cytoplasmic nuclear protein import factor p97.

Authors:  N C Chi; E J Adam; S A Adam
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  27 in total

1.  Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus.

Authors:  Kurt E Gustin; Peter Sarnow
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Novel nuclear herniations induced by nuclear localization of a viral protein.

Authors:  Cristen C Hoyt; Ron J Bouchard; Kenneth L Tyler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virus.

Authors:  Ewan F Dunn; John H Connor
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

4.  Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.

Authors:  Jianrong Li; John S Chorba; Sean P J Whelan
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

5.  Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB.

Authors:  Jing Ye; Zheng Chen; Yunchuan Li; Zikai Zhao; Wen He; Ali Zohaib; Yunfeng Song; Chenglin Deng; Bo Zhang; Huanchun Chen; Shengbo Cao
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

6.  Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores.

Authors:  George A Belov; Peter V Lidsky; Olga V Mikitas; Denise Egger; Konstantin A Lukyanov; Kurt Bienz; Vadim I Agol
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

8.  New mRNAs are preferentially translated during vesicular stomatitis virus infection.

Authors:  Zackary W Whitlow; John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.

Authors:  Natalia Garmashova; Svetlana Atasheva; Wenli Kang; Scott C Weaver; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  hnRNPs Relocalize to the cytoplasm following infection with vesicular stomatitis virus.

Authors:  Elizabeth L Pettit Kneller; John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.